Back to Top

Benchling & Beam Therapeutics: A Two-Pronged Approach to Automation for Gene Therapy Research


Aug 24, 2021


Beam Therapeutics is developing a new class of genetic medicines using novel base editing technology that enables them to edit precise sets of base pairs without introducing a double-stranded break in the DNA. Beam needs to evaluate thousands of biological samples each week, but their digital infrastructure wasn't set up for that scale. Together, Benchling and Beam developed a cutting-edge, two-pronged approach to unlock data and robotics automation at a vastly greater scale than ever before.

Application File

Benchling & Beam Case Study.pdf